Exercise Versus Diet in the Treatment of Nonalcoholic Fatty Liver Disease
Study Details
Study Description
Brief Summary
The central hypothesis of this proposal is that a reduction in hepatic mitochondrial function is the main pathophysiology behind NAFLD (Non-Alcoholic Fatty Liver Disease) and NASH (Non alcoholic steatohepatitis). The investigators further hypothesize that lifestyle modifications through aerobic exercise training without weight loss or diet-induced weight loss are effective in reducing NAFLD parameters by improving hepatic mitochondrial content and function in human subjects.
The investigators propose a randomized, controlled human clinical trial to compare the effects of aerobic exercise training (without weight loss) versus diet-induced weight loss (without exercise) in individuals who have NAFLD or liver biopsy-confirmed NASH
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Fatty Liver Disease) and NASH (Non alcoholic steatohepatitis). The investigators further hypothesize that lifestyle modifications through aerobic exercise training without weight loss or diet-induced weight loss are effective in reducing NAFLD parameters by improving hepatic mitochondrial content and function in human subjects.
The investigators propose a randomized, controlled human clinical trial to compare the effects of aerobic exercise training (without weight loss) versus diet-induced weight loss (without exercise) in individuals who have NAFLD or liver biopsy-confirmed NASH
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: Weight loss 10% weight loss in 24 weeks time period through nutritional counseling. |
Behavioral: Weight loss
Nutritional counseling
|
Active Comparator: Exercise without weight loss 24 weeks under direct supervision. |
Behavioral: Exercise
Under direct supervision
|
No Intervention: Control No change in usual exercise levels or food intake. |
Outcome Measures
Primary Outcome Measures
- NASH ( Non alcoholic steatohepatitis score) on liver biopsy [baseline and 24 weeks]
Secondary Outcome Measures
- Liver Function Tests [Baseline and 24 weeks]
ALT/AST.
- DXA Scan [Baseline and 24 weeks]
- Ultrasonographical changes in liver echotexture [Baseline and 24 weeks]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
sedentary individual between
-
age group 18-60 years old
-
elevated Liver Function Tests (LFT's) with fatty liver on ultrasound and biopsy proven NASH
Exclusion Criteria:
-
significant history of alcohol consumption > 20 gm/day (> 2 drinks / day)
-
evidence of other causes of hepatitis including positive screening B & C, autoimmune hepatitis, hemochromatosis, celiac disease, Wilson's disease, alpha 1 antitrypsin deficiency or medication-induced hepatitis
-
Subjects with planned exercise > 30-60 minutes per week
-
BMI < 25 or > 44 kg/m2
-
clinical or biochemical evidence of decompensated liver disease, advanced cardiac or renal disease
-
changes in last 3 months the dose of oral hypoglycemic medication and statin,
-
positive stress test
-
pregnant women
-
demented individuals who cannot give consent
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University Hospital | Columbia | Missouri | United States | 65212 |
Sponsors and Collaborators
- University of Missouri-Columbia
Investigators
- Principal Investigator: Jamal Ibdah, MD; PhD, University of Missouri-Columbia
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 1142777